| Management of sepsis in the critically ill patient: key aspects. | |
| | |
MedLine Citation:
|
PMID: 17020431 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Severe sepsis is a major cause of morbidity and mortality in the critically ill patient. Management involves identification and treatment of the underlying causative infection, with antimicrobial agents and surgery where necessary, haemodynamic resuscitation with fluids and vasoactive agents, steroids (for septic shock) and immunomodulation with drotrecogin-alpha (activated), where not contraindicated. Every effort must be made to identify sepsis early so as to optimise the patient's chances of a good outcome. |
| | |
Authors:
|
Jean-Louis Vincent |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Expert opinion on pharmacotherapy Volume: 7 ISSN: 1744-7666 ISO Abbreviation: Expert Opin Pharmacother Publication Date: 2006 Oct |
Date Detail:
|
Created Date: 2006-10-05 Completed Date: 2006-10-11 Revised Date: 2008-04-14 |
Medline Journal Info:
|
Nlm Unique ID: 100897346 Medline TA: Expert Opin Pharmacother Country: England |
Other Details:
|
Languages: eng Pagination: 2037-45 Citation Subset: IM |
Affiliation:
|
Department of Intensive Care, Erasme University Hospital, Route de Lennik 808, B-1070 Brussels, Belgium. jlvincen@ulb.ac.be |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Anti-Infective Agents / economics, therapeutic use* Humans Infection Control / methods* Intensive Care Units / statistics & numerical data* Multicenter Studies as Topic Nutritional Support Protein C / economics, therapeutic use* Randomized Controlled Trials as Topic Recombinant Proteins / economics, therapeutic use Resuscitation / methods* Sepsis* / drug therapy, etiology, mortality Survival Analysis |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Infective Agents; 0/Protein C; 0/Recombinant Proteins; 0/drotrecogin alfa activated |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Antiviral treatment of hepatitis C.
Next Document: Economic evaluation of sustained sedation/analgesia in the intensive care unit.